User profiles for Rob Challen

Robert Challen

University of Exeter / Taunton NHS Trust
Verified email at exeter.ac.uk
Cited by 1863

Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study

R Challen, E Brooks-Pollock, JM Read, L Dyson… - bmj, 2021 - bmj.com
Objective To establish whether there is any change in mortality from infection with a new
variant of SARS-CoV-2, designated a variant of concern (VOC-202012/1) in December 2020, …

Artificial intelligence, bias and clinical safety

R Challen, J Denny, M Pitt, L Gompels… - BMJ quality & …, 2019 - qualitysafety.bmj.com
In medicine, artificial intelligence (AI) research is becoming increasingly focused on applying
machine learning (ML) techniques to complex problems, and so allowing computers to …

[HTML][HTML] Severity of Omicron (B. 1.1. 529) and Delta (B. 1.617. 2) SARS-CoV-2 infection among hospitalised adults: A prospective cohort study in Bristol, United …

C Hyams, R Challen, R Marlow, J Nguyen… - The Lancet Regional …, 2023 - thelancet.com
Background There is an urgent public health need to evaluate disease severity in adults
hospitalised with Delta and Omicron SARS-CoV-2 variant infections. However, limited data exist …

[HTML][HTML] Effectiveness of BNT162b2 COVID-19 vaccination in prevention of hospitalisations and severe disease in adults with SARS-CoV-2 Delta (B. 1.617. 2) and …

A Chatzilena, C Hyams, R Challen… - The Lancet Regional …, 2023 - thelancet.com
Background Whilst other studies have reported the effectiveness of mRNA vaccination against
hospitalisation, including emergency department or intensive care admission, few have …

Relative vaccine effectiveness (rVE) of mRNA COVID-19 boosters in the UK vaccination programme, during the Spring-Summer (monovalent vaccine) and Autumn …

A Chatzilena, C Hyams, R Challen, R Marlow, J King… - medRxiv, 2023 - medrxiv.org
Background Understanding the relative vaccine effectiveness (rVE) of new COVID-19 vaccine
formulations against SARS-CoV-2 infection is an urgent public health priority. A precise …

Early epidemiological signatures of novel SARS-CoV-2 variants: establishment of B. 1.617. 2 in England

R Challen, L Dyson, CE Overton, LM Guzman-Rincon… - MedRxiv, 2021 - medrxiv.org
The rapid emergence of SARS-CoV-2 mutants with new phenotypic properties is a critical
challenge to the control of the ongoing pandemic. B.1.1.7 was monitored in the UK through …

Clinical decision-making and algorithmic inequality

R Challen, L Danon - BMJ Quality & Safety, 2023 - qualitysafety.bmj.com
Decision support algorithms based on historical data will make recommendations that are
influenced by past inequality. Detailed historical health data contain patterns that identify …

Short-term projections based on early Omicron variant dynamics in England

MJ Keeling, E Brooks-Pollock, R Challen, L Danon… - MedRxiv, 2021 - medrxiv.org
Throughout the ongoing COVID-19 pandemic, the worldwide transmission and replication of
SARS-COV-2, the causative agent of COVID-19 disease, has resulted in the opportunity for …

[HTML][HTML] Relative vaccine effectiveness of mRNA COVID-19 boosters in people aged at least 75 years during the spring-summer (monovalent vaccine) and autumn …

A Chatzilena, C Hyams, R Challen, R Marlow… - …, 2023 - eurosurveillance.org
Background Understanding the relative vaccine effectiveness (rVE) of new COVID-19 vaccine
formulations against SARS-CoV-2 infection is a public health priority. A precise analysis of …

Commentary on the use of the reproduction number R during the COVID-19 pandemic

…, F Ball, E Brooks-Pollock, R Challen… - … Methods in Medical …, 2022 - journals.sagepub.com
Since the beginning of the COVID-19 pandemic, the reproduction number [Formula: see text]
has become a popular epidemiological metric used to communicate the state of the …